About The Journal
Journal of Molecular Oncology Research is refers to the process of tumor formation within the molecular level and its effects along with various therapeutic methods in the cancer treatment.
Cancers are often managed through discussion on multi-disciplinary cancer conferences where medical oncologists, surgical oncologists, radiation oncologists, pathologists, radiologists, and organ-specific oncologists meet to find the best possible management for an individual patient considering the physical, social, psychological, emotional, and financial status of the patient. It is very important for oncologists to keep up-to-date with the latest advancements in oncology, as changes in the management of cancer are quite common.
This open access journal ensures wide spread dissemination of research work as original Commentary, Review Article, Perspective, Rapid Communication, Opinion Articles and Letter to Editor, discussing emerging concepts in cancer research, cancer diagnosis, prevention and care, Chemotherapy.
The journal follows single line peer reviewed process.
Submit Mansucript at Online Manucript Submission System or send as an email attachment to moloncol@molecularbiol.com and/or moloncol@eclinicalsci.com
Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Molecular Oncology Research is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
h-index
Articles published in Journal of Molecular Oncology Research have been cited by esteemed scholars and scientists all around the world. Journal of Molecular Oncology Research has got h-index 5 , which means every article in Journal of Molecular Oncology Research has got 5 average citations.
editorialservice@alliedacademies.org
Just Published Articles View More
Rapid Communication December 06, 2024
P.1-2
Unraveling the links between bone marrow and genomic instability in acute cancer pathologies.
Chad Arend*
DOI:
Short Communication December 06, 2024
P.1-2
Unraveling molecular pathology in acute lymphoblastic leukemia: Insights from bone marrow studies.
Eliana Jen*
DOI:
Perspective December 06, 2024
P.1-2
Insights into molecular pathology: Bone marrow tumor markers.
DOI:
Opinion Article December 06, 2024
P.1-2
Understanding the molecular pathology of bone marrow pneumonia.
Mark Ewalt*
DOI:
Commentary December 06, 2024
P.1-2
Insights into molecular pathology through bone marrow tissue biopsy.
Seng Siow*
DOI:
Short Communication December 06, 2024
P.1-1
Advances in molecular pathology of bone marrow cancer.
Sapari Yong*
DOI: